Unflame

IBS · Pattern story 04

Why a stomach bug can leave a years-long footprint in the gut

In May 2000, farm runoff contaminated the water supply of Walkerton, Ontario, and over 2,000 people fell ill. Two years later, long after the water was clean, 36% of those who had been poisoned still had chronic bowel symptoms, against 10% of neighbours who had not. A brief infection had left a long shadow.

By Laxmanna · Updated 2026-10-21 · 7 min read · 14 sources

1 in 7

adults (14.5%) meet IBS criteria months after infectious gastroenteritis, across 47 studies and 28,170 people.[1]

~85%

recover from the infection with no lasting bowel problem. Post-infectious IBS is common, not inevitable.[1]

~60%

of people with post-infectious IBS no longer meet criteria five years on; roughly 40% still have symptoms.[2]

A short infection, a long story

Infectious gastroenteritis is one of the clearest documented population-level triggers for new-onset IBS. Pooling 47 observational studies and 28,170 people, 14.5% met IBS criteria months after an episode, and the odds were 4.3 times higher than in unexposed controls (95% CI 3.1 to 5.9).[1] The flip side is the number that matters most if you are reading this after a bad week: roughly 85% of people do not develop lasting symptoms.[1][2]

The headline figure is not precise. Rates differ by which diagnostic criteria are used (about 20% under Rome III, 10.7% under Rome IV), the studies are extremely heterogeneous, and people with symptoms are more likely to answer follow-up surveys.[1] Treat 1 in 7 as the right order of magnitude rather than an exact risk.

Acute gastroenteritis
days 0–14
~85%full recovery
~15%post-infectious IBS at 3+ months
→ ~60% resolve over 5 years · ~40% persist
The two branches after an infection, from the pooled meta-analysis and the long-term outbreak cohorts.[1][2][3]

Who is more likely, and what cannot be predicted

The most consistent predictor is how severe and how long the acute illness was. Diarrhoea lasting more than two weeks raised the odds roughly 2.5-fold (OR 2.58), and being hospitalised raised them by about 65% (OR 1.65).[1] Pathogen type matters too, in a rough ladder: protozoa such as Giardia carry the highest risk, then bacteria, then viruses.[1][2] Female sex and pre-existing anxiety also appear as population-level markers.[1][2]

Antibiotics are often blamed. In the pooled analysis, antibiotic use during the acute illness showed no independent association (OR 1.06), and the apparent link in some studies is explained by confounding by indication: sicker patients with longer diarrhoea are the ones who get prescribed antibiotics.[1][2]

All of these are population-level associations. No validated test or model can tell an individual whether they will develop post-infectious IBS, and no blood or stool test confirms that an infection caused someone's IBS.[2][4][5]

What remains after the pathogen is gone

For the minority who develop lasting symptoms, it is not because the bacteria or virus is still there. With rare exceptions, notably Giardia that was never eradicated, the acute immune response clears the pathogen.[2][6] What small human biopsy studies find instead is a set of subtle, low-grade changes: more T cells and mast cells in the gut lining than in controls, increased intestinal permeability in a subset of patients (reported anywhere from 16% to 62%), shifts in the serotonin-producing enterochromaffin cells that vary by pathogen, and heightened sensitivity of the gut's nerves to normal digestion.[2][7][8][9]

Three qualifiers matter. These changes are subclinical: they are not microscopic colitis and they are not inflammatory bowel disease.[2][4] They occur in subsets, not in everyone.[2] And some of the most dramatic findings come from animals only. Rodent infection models show 20 to 30% loss of enteric neurons; this has never been demonstrated in human post-infectious IBS.[2] The elegant mouse work showing bacterial infection can trigger a local allergic-type response to food antigens has had only a very small human pilot (12 people, two of them post-infectious).[2][10]

In plain terms: the gut's regulatory systems (barrier, immune tone, gut-brain signalling) stay slightly re-tuned after the infection has gone. That is a different thing from an active infection or ongoing tissue damage.

Does it get better?

For many, yes, slowly. Natural-history studies show symptom persistence of around 50% at one to four years and around 40% beyond five years, which means nearly 60% of people with post-infectious IBS no longer meet criteria over five years.[1][2][3] Post-viral cases tend to resolve faster, often within 6 to 12 months.[1][2]

Trajectories differ by pathogen. In Walkerton, where the outbreak was bacterial, the proportion with IBS declined steadily over eight years.[3] In Bergen, Norway, after a waterborne Giardia outbreak, initial rates were much higher (30 to 46%) and tended to plateau rather than fall.[11][12]

One more reason not to self-manage persistent symptoms: a database cohort found that gastroenteritis modestly raises the risk of new-onset inflammatory bowel disease in the first year afterwards (hazard ratio around 4.1), so a doctor's workup matters.[13][2]

What this means for you

  • Bowel symptoms after a stomach bug are common, and most people recover. If yours have lasted past about three months, that is the point at which post-infectious IBS is usually considered, and the point to see a doctor.
  • Persistent symptoms do not mean the infection is still active. They reflect a gut that is more sensitive and slightly re-tuned.
  • Whether you took antibiotics is unlikely to be the deciding factor; the severity and duration of the illness itself is the more consistent marker.
  • There is no 'post-infectious protocol'. Randomised trials of mesalamine and corticosteroids showed no overall benefit, and the Rome working team did not endorse routine antibiotics or probiotics as first-line options for post-infectious IBS.[2] Management is individual and clinician-guided.
  • If you log symptoms, mark the infection date. A clear start date is one of the few things that makes post-infectious IBS recognisable, and your doctor will want it.

Questions for your doctor

  1. My bowel symptoms started after a stomach infection about [date]. Does that fit post-infectious IBS?
  2. Which conditions that mimic IBS (coeliac disease, inflammatory bowel disease, bile acid diarrhoea, persistent Giardia) have been excluded, and what tests were used?
  3. Is a faecal calprotectin or blood test appropriate given that gastroenteritis raises IBD risk in the first year?
  4. Which subtype do my symptoms fit (diarrhoea, constipation, mixed), and how does that change the approach?
  5. What is a realistic timeline for improvement, and what should prompt me to come back sooner?

When to seek care

Arrange medical evaluation for unintentional weight loss, rectal bleeding or black stools, diarrhoea or pain that wakes you at night, unexplained iron-deficiency anaemia, raised inflammatory markers (CRP, ESR, faecal calprotectin), new symptoms starting after age 50, or a family history of inflammatory bowel disease, coeliac disease or bowel cancer.[4][5][14] Post-infectious IBS is a diagnosis a physician makes after ruling these out.

Things people hear, and what the evidence says

"If you had food poisoning, that's what caused your IBS."
Population odds are raised 4.3-fold, but about 85% of people recover fully. Association at the group level cannot prove cause in one person.[1][2]
"The bacteria are still in there."
Pathogens are cleared in the vast majority of cases. Lasting symptoms come from low-grade immune, barrier and nerve-sensitivity changes, not ongoing infection (except uneradicated Giardia).[2][6]
"Antibiotics for the stomach flu gave me IBS."
Pooled analysis shows no independent association (OR 1.06). Sicker patients get antibiotics more often, which is what creates the apparent link.[1]
"Infection destroyed a third of my gut nerves."
That figure comes from rodent models. It has not been shown in humans with post-infectious IBS.[2]
"An anti-inflammatory will fix it."
Trials of mesalamine and prednisolone showed no overall symptom benefit over placebo in post-infectious IBS.[2]

Sources

Primary human studies are marked "primary"; reviews, guidelines and models are labelled. Where a source is an abstract only, that is stated.

  1. Porcari S et al. Prevalence and risk factors of post-infection IBS: systematic review and meta-analysis of 47 studies. Gut 2024 — primary. https://gut.bmj.com/content/gutjnl/73/9/1431.full.pdf
  2. Barbara G et al. Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome. Gastroenterology 2019 — consensus report. https://theromefoundation.org/wp-content/uploads/Rome-Foundation-Working-Team-Report-on-Post-Infection-Irritable-Bowel-Syndrome-2.pdf
  3. Marshall JK et al. Eight-year prognosis of post-infectious IBS following waterborne bacterial dysentery (Walkerton). Gut 2010 — primary cohort. https://gut.bmj.com/content/59/5/605
  4. Vasant DH et al. British Society of Gastroenterology guidelines on the management of IBS. Gut 2021 — guideline. https://gut.bmj.com/content/gutjnl/early/2021/04/26/gutjnl-2021-324598.full.pdf
  5. Lacy BE et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol 2021 — guideline. https://journals.lww.com/ajg/fulltext/2021/01000/acg_clinical_guideline__management_of_irritable.11.aspx
  6. Berumen A, Edwinson AL, Grover M. Post-infection irritable bowel syndrome. Gastroenterol Clin North Am 2021 — review. https://pmc.ncbi.nlm.nih.gov/articles/PMC8144546/
  7. Spiller RC et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric IBS. Gut 2000 — primary. https://pmc.ncbi.nlm.nih.gov/articles/PMC1728147/
  8. Dunlop SP et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in post-infectious IBS. Gastroenterology 2003 — primary. https://pubmed.ncbi.nlm.nih.gov/14724817/
  9. Gwee KA et al. Increased rectal mucosal expression of interleukin 1β in recently acquired post-infectious IBS. Gut 2003 — primary. https://pmc.ncbi.nlm.nih.gov/articles/PMC1773606/
  10. Aguilera-Lizarraga J et al. Local immune response to food antigens drives meal-induced abdominal pain. Nature 2021 — mouse plus small human pilot. https://pmc.ncbi.nlm.nih.gov/articles/PMC7610810/
  11. Wensaas KA et al. IBS and chronic fatigue 3 years after acute giardiasis (Bergen). Gut 2012 — primary cohort. https://pubmed.ncbi.nlm.nih.gov/21911849/
  12. Litleskare S et al. Prevalence of IBS and chronic fatigue 10 years after Giardia infection. Neurogastroenterol Motil 2019 — primary cohort. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849782/
  13. García Rodríguez LA et al. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006 — database cohort. https://pubmed.ncbi.nlm.nih.gov/16697722/
  14. NIDDK. Diagnosis of irritable bowel syndrome — patient information. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/diagnosis

Written by Laxmanna · Research-led health writer. Every explainer on Unflame starts from a structured evidence dossier: primary studies retrieved, claims tabulated, contradictions logged, and wording checked against what the sources can support. How the dossiers are built.

Related

IBS

Why IBS hits minutes after a meal, when the food is still in your stomach

Solid food takes 2 to 5 hours to reach the colon, so cramps five minutes into a meal cannot be 'the food going straight through'.

Read the explainer IBS

Why the same food can hurt on Tuesday and not on Friday

84% of people with IBS report food triggers, yet 61% of their real-life meals cause no symptoms, and up to a third of people flare on blinded placebo.

Read the explainer